The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia
Baldeep Wirk, Rami Hawila · 2026
Read The Impact of Induction With Azacitidine and Venetoclax Versus Intensive Chemotherapy on Outcomes After Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia by Baldeep Wirk, Rami Hawila (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13568785.txt.
Description
Baldeep Wirk and Rami Hawila compare two starter drug paths before stem cell transplant in new leukemia cases, in this 2026 study. A gentler two-drug combo is standard for older or frail patients; harsh chemo suits the fit. Whether the gentler start harms later transplant results was unclear.
One center's records held 14 combo patients and 17 chemo patients, all reaching remission first. The combo group carried far more high-risk disease. One-year survival, relapse, and graft illness rates all landed close between groups. Statistical models found no harm from the gentler start. The authors back combo starts even for fit patients headed to transplant.
Catalog record
| CREATOR | Baldeep Wirk, Rami Hawila |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |